Background Patient support programs (PSPs), including medication management and
counseling, have the potential to improve care in chronic disease states with complex …

Nonadherence to aspects of the management of End‐Stage Kidney Disease (ESKD) is
common. Estimates of nonadherence vary with assessment method. Whilst readily available …

In recent years, the imbalance in phosphate homeostasis in patients with end-stage renal
disease (ESRD) has been the subject of much research. It appears that, while …

Hyperphosphatemia is common in chronic kidney disease (CKD) and is treated by dietary
measures, dialysis techniques and/or phosphate binders. For the present review PubMed …

Purpose Non-adherence to chronic medication remains an important problem with vast
consequences and without solutions to date. Nurses are well positioned to provide …

Background People with end-stage kidney disease (ESKD) develop impaired excretion of
phosphate. Hyperphosphatemia develops in ESKD as a result of the kidney's reduced ability …

Background Adherence to phosphate binder treatment is important to prevent high serum
phosphate level in chronic dialysis patients. We therefore wanted to investigate patient …

Objective: to evaluate the effectiveness of an educational nursing intervention to reduce
hyperphosphataemia in chronic renal patients on hemodialysis. Method: quasi-experimental …

Objective To systematically retrieve and condense the best possible evidence on the
successful interventions that targeted enhancement of therapeutic and lifestyle …

Background Hyperphosphatemia is a common consequence in end stage renal disease. It is
associated with increased cardiovascular risk and mortality, also development of …